NCT01407666

Brief Summary

This prospective, randomized study is intended to assess the efficacy and safety of bilateral continuous paravertebral blocks compared to continuous epidural block for open liver resection. Hypotheses: Bilateral paravertebral blocks are: 1) equally effective in controlling the perioperative pain; and 2) safe, with less frequent complications following open liver resection when compared to continuous epidural block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 17, 2011

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 2, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

December 3, 2014

Status Verified

December 1, 2014

Enrollment Period

4 years

First QC Date

February 17, 2011

Last Update Submit

December 2, 2014

Conditions

Keywords

paravertebral blockepidural blockpain managementliver resectioncomparison

Outcome Measures

Primary Outcomes (1)

  • Pain immediately after maximum incentive spirometry

    Pain will be assessed using an 11-point verbal numerical pain scale (VAS) with 0 indicating no pain and 10 indicating the worst pain imaginable;(21) pain will be determined 24 hours postoperatively immediately after maximum incentive spirometry.

    24 hours postoperatively

Secondary Outcomes (1)

  • date of the removal of the catheter

    up to one week after the surgery

Study Arms (2)

Bilateral paravertebral blocks

EXPERIMENTAL

Bilateral continuous paravertebral blocks for open liver resection

Procedure: paravertebral blocks

epidural block

NO INTERVENTION

received thoracic epidural block for open liver resection

Interventions

use bilateral thoracic paravertebral blocks for pain control

Also known as: regional anesthesia
Bilateral paravertebral blocks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists physical status (ASAPS) I to III patients aged over 18 years and scheduled to undergo elective open liver resection at UPMC Presbyterian/Montefiore Hospital will be screened for enrollment in the study. One hundred (100) patients will be enrolled in this study with equal numbers (n = 50) in each arm of the trial. In order to avoid skewed sex difference between the two groups, the sex will be allocated.

You may not qualify if:

  • non elective surgery,
  • ASAPS IV or greater,
  • age younger than 18 years,
  • any contraindication to the placement of an epidural catheter or bilateral paravertebral catheters
  • chronic pain conditions
  • preoperative opioid use
  • coagulation abnormalities or patients who are expected to be on therapeutic anticoagulants postoperatively
  • allergy to any of the drugs/agents used our study protocol
  • preoperative chronic renal dysfunction, who requires renal replacement therapy or serum creatinine greater than 1.4 mg/dL
  • altered mental status (not oriented to place, person, or time),
  • any comorbid conditions that, in the judgment of the consulting surgeon or anesthesiologist, would proscribe the patient from any aspect of the study, -
  • inability to provide adequate informed consent
  • refusal to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh School of Medicine

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Liver DiseasesPainAgnosia

Interventions

Anesthesia, Conduction

Condition Hierarchy (Ancestors)

Digestive System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Officials

  • Tetsuro Sakai, MD, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2011

First Posted

August 2, 2011

Study Start

August 1, 2010

Primary Completion

August 1, 2014

Study Completion

November 1, 2014

Last Updated

December 3, 2014

Record last verified: 2014-12

Locations